Classical and Non-Classical Progesterone Signaling in Breast Cancers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Classical and Non-Classical Progesterone Signaling in Breast Cancers
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2440
Publisher
MDPI AG
Online
2020-08-28
DOI
10.3390/cancers12092440
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study
- (2020) Guiju Cai et al. GYNECOLOGICAL ENDOCRINOLOGY
- Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
- (2020) Diego A. Pedroza et al. BRITISH JOURNAL OF CANCER
- Tumour lineage shapes BRCA-mediated phenotypes
- (2019) Philip Jonsson et al. NATURE
- PGRMC2 is an intracellular haem chaperone critical for adipocyte function
- (2019) Andrea Galmozzi et al. NATURE
- Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications
- (2019) Ana Godoy-Ortiz et al. Frontiers in Oncology
- Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
- (2019) Cristiana Marian Grapa et al. International Journal of Nanomedicine
- Differences in Breast Cancer Survival by Molecular Subtypes in the United States
- (2018) Nadia Howlader et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment
- (2018) Won Kyung Cho et al. Clinical Breast Cancer
- Overcoming endocrine resistance in hormone receptor–positive breast cancer
- (2018) A. AlFakeeh et al. Current Oncology
- Fulvestrant for the treatment of advanced breast cancer
- (2018) Sophie A. Blackburn et al. Expert Review of Anticancer Therapy
- Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models
- (2018) Katherine A. Leehy et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment
- (2018) Peter A. van Dam et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Environmental radon exposure and breast cancer risk in the Nurses’ Health Study II
- (2017) Trang VoPham et al. Environmental Health
- Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
- (2017) Li Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
- (2017) Paola A. Rojas et al. JNCI-Journal of the National Cancer Institute
- Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer
- (2017) Xiangyan Ruan et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer
- (2017) Svasti Haricharan et al. Cancer Discovery
- Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
- (2017) Marina Willibald et al. Oncotarget
- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
- (2017) Paola A. Rojas et al. JNCI-Journal of the National Cancer Institute
- The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology
- (2016) Michael A. Cahill et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors
- (2016) Monica Salazar et al. GENE
- Progesterone Receptor Signaling Mechanisms
- (2016) Sandra L. Grimm et al. JOURNAL OF MOLECULAR BIOLOGY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Prevention of breast cancer
- (2016) Ian N Olver MEDICAL JOURNAL OF AUSTRALIA
- Membrane progesterone receptors in reproduction and cancer
- (2016) Paulina Valadez-Cosmes et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance
- (2016) Yasuaki Kabe et al. Nature Communications
- Nuquantus: Machine learning software for the characterization and quantification of cell nuclei in complex immunofluorescent tissue images
- (2016) Polina Gross et al. Scientific Reports
- Identification of a novel putative interaction partner of the nucleoporin ALADIN
- (2016) Ramona Jühlen et al. Biology Open
- Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
- (2015) Soo Youn Bae et al. BMC CANCER
- Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
- (2015) Patricia A. Mote et al. BREAST CANCER RESEARCH AND TREATMENT
- Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis
- (2015) Thiyagarajan Boopalan et al. CANCER SCIENCE
- Mammary gland development: cell fate specification, stem cells and the microenvironment
- (2015) J. L. Inman et al. DEVELOPMENT
- Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming
- (2015) C. H. Diep et al. MOLECULAR CANCER RESEARCH
- Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway
- (2015) Xiaojuan Wu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Progesterone and Src Family Inhibitor PP1 Synergistically Inhibit Cell Migration and Invasion of Human Basal Phenotype Breast Cancer Cells
- (2015) Mingxuan Xie et al. Biomed Research International
- Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone
- (2015) Rowan T. Chlebowski et al. JAMA Oncology
- Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland
- (2014) Nadia Okolowsky et al. DEVELOPMENTAL BIOLOGY
- Progesterone Receptor–Cyclin D1 Complexes Induce Cell Cycle–Dependent Transcriptional Programs in Breast Cancer Cells
- (2014) Gwen E. Dressing et al. MOLECULAR ENDOCRINOLOGY
- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study
- (2013) C A Purdie et al. BRITISH JOURNAL OF CANCER
- Progesterone – promoter or inhibitor of breast cancer
- (2013) H. Kuhl et al. CLIMACTERIC
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
- (2013) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Research Resource: Progesterone Receptor Targetome Underlying Mammary Gland Branching Morphogenesis
- (2013) Ashlee R. Lain et al. MOLECULAR ENDOCRINOLOGY
- A Truncated Progesterone Receptor (PR-M) Localizes to the Mitochondrion and Controls Cellular Respiration
- (2013) Qunsheng Dai et al. MOLECULAR ENDOCRINOLOGY
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Tracking progesterone receptor-mediated actions in breast cancer
- (2013) Todd P. Knutson et al. PHARMACOLOGY & THERAPEUTICS
- Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast
- (2013) T. Tanos et al. Science Translational Medicine
- Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer
- (2013) Li-Jun Di et al. Nature Communications
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Progesterone Directly and Rapidly Inhibits GnRH Neuronal Activity via Progesterone Receptor Membrane Component 1
- (2012) Nicholas Michael Bashour et al. ENDOCRINOLOGY
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- (2012) Garnet L Anderson et al. LANCET ONCOLOGY
- Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast
- (2012) H.N. Hilton et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study
- (2012) Mingxuan Xie et al. PLoS One
- Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line
- (2012) Junaid A. Khan et al. PLoS One
- In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1
- (2012) Christian Albrecht et al. STEROIDS
- PGRMC2, a yet uncharacterized protein with potential as tumor suppressor, migration inhibitor, and regulator of cytochrome P450 enzyme activity
- (2012) Alexandra Wendler et al. STEROIDS
- Membrane Progesterone Receptors (mPRs) Mediate Progestin Induced Antimorbidity in Breast Cancer Cells and Are Expressed in Human Breast Tumors
- (2012) Gwen E. Dressing et al. Hormones & Cancer
- Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells
- (2011) Zhen-Ning Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- RANKL inhibition: a promising novel strategy for breast cancer treatment
- (2011) Eva González-Suárez Clinical & Translational Oncology
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- (2011) J. P. Thakkar et al. ONCOLOGIST
- Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor
- (2011) Yefei Pang et al. STEROIDS
- The normal menstrual cycle in women
- (2010) M. Mihm et al. ANIMAL REPRODUCTION SCIENCE
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
- (2010) Rowan T. Chlebowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity
- (2010) Ikhlas S. Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Progesterone Receptor Membrane Component 1 (Pgrmc1): A Heme-1 Domain Protein That Promotes Tumorigenesis and Is Inhibited by a Small Molecule
- (2010) I. S. Ahmed et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
- (2010) M. Beleut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells
- (2009) H. Neubauer et al. CLIMACTERIC
- High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer
- (2009) Pankaj G. Roy et al. INTERNATIONAL JOURNAL OF CANCER
- Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
- (2009) A. C. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cytoplasmic 60 kDa progesterone receptor isoform predominates in the human amniochorion and placenta at term
- (2009) Anthony H Taylor et al. Reproductive Biology and Endocrinology
- Molecular profiles of progesterone receptor loss in human breast tumors
- (2008) Chad J. Creighton et al. BREAST CANCER RESEARCH AND TREATMENT
- Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors
- (2008) Emily J. Faivre et al. MOLECULAR ENDOCRINOLOGY
- Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
- (2008) E. W. Blank et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started